SCHEMBL63740

SCHEMBL63740

CCCCCCCCCCCCCCCCCCCC(O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.55
GPR84 Q9NQS5 7/20 0.54
SPHK1 Q9NYA1 2/20 0.54
FFAR1 O14842 2/20 0.54
CYP2D6 P10635 2/20 0.50
GMNN O75496 1/20 0.50
POLB P06746 1/20 0.50
THPO P40225 1/20 0.50
MTOR P42345 1/20 0.50
BLM P54132 1/20 0.50
KDM4E B2RXH2 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50
CETP P11597 1/20 0.50
HTT P42858 1/20 0.50
UBE2N P61088 1/20 0.50
TSHR P16473 1/20 0.50
THRB P10828 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL319770 1.00 LMNA (0.55) LMNAGPR84SPHK1FFAR1CYP2D6
SCHEMBL5283767 1.00 LMNA (0.55) LMNAGPR84SPHK1FFAR1CYP2D6
SCHEMBL162645 1.00 LMNA (0.55) LMNAGPR84SPHK1FFAR1CYP2D6
SCHEMBL113627 1.00 LMNA (0.55) LMNAGPR84SPHK1FFAR1CYP2D6
SCHEMBL3161688 1.00 LMNA (0.55) LMNAGPR84SPHK1FFAR1CYP2D6
SCHEMBL3028196 1.00 LMNA (0.55) LMNAGPR84SPHK1FFAR1CYP2D6
SCHEMBL3129966 1.00 LMNA (0.55) LMNAGPR84SPHK1FFAR1CYP2D6
SCHEMBL10921948 1.00 LMNA (0.55) LMNAGPR84SPHK1FFAR1CYP2D6
SCHEMBL318331 1.00 LMNA (0.55) LMNAGPR84SPHK1FFAR1CYP2D6
SCHEMBL22653488 1.00 LMNA (0.55) LMNAGPR84SPHK1FFAR1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119912668-A Synthesis of linear aliphatic polyesters 丰益国际有限公司 2025-05-02 CN claimed
CN-114867351-A 4' -halo-containing nucleotide and nucleoside therapeutic compositions and uses related thereto 埃默里大学 2022-08-05 CN claimed
CN-109694423-B Catalyst component for ethylene polymerization, preparation method thereof and catalyst for ethylene polymerization 中国石油化工股份有限公司 2021-07-30 CN claimed
US-7578875-B2 Black inks and method for making same XEROX CORPORATION (US) 2009-08-25 US claimed
US-20070119337-A1 Black inks and method for making same XEROX CORPORATION 2007-05-31 US claimed
US-5288813-A Polyester resin comprising ether-containing polyol component, diol component, polycarboxylic acid component, acid anhydride, and epoxy compound TOYO BOSEKI KABUSHIKI KAISHA (JP) 1994-02-22 US claimed
US-4012251-A ELECTROPHOTOGRAPHY, FLUORENONE OR DICYANOMETHYLENEFLUORENE POLYESTER XEROX CORPORATION (US) 1977-03-15 US claimed
US-3993605-A SURFACTANT OF VICINAL ALKANEDIOL ESTERS CHEMISCHE WERKE HULS AKTIENGESELLSCHAFT 1976-11-23 US claimed
EP-4717248-A2 MANUFACTURING METHOD OF RESIN BLANK FOR DENTAL CUTTING AND MACHINING Shofu Inc. (JP) 2026-04-01 EP disclosed
US-20260028440-A1 Curable Composition for Producing Transparent Orthodontic Attachments SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2026-01-29 US disclosed
EP-4381014-B1 POLYMER COMPOSITION BASED ON POLY(METH)ACRYLIMIDE FOR TRIBOLOGICAL APPLICATIONS ROEHM GMBH (DE) 2025-10-01 EP disclosed
EP-4622590-A1 CURABLE COMPOSITION FOR USE IN A PROCESS OF TREATING A DENTAL SITUATION IN THE MOUTH OF A PATIENT Solventum Intellectual Properties Company (US) 2025-10-01 EP disclosed
US-20250289950-A1 POLY(METH)ACRYLAT IMPACT MODIFIER WITH REDUCED METAL ION CONTENT AND METHOD FOR ITS PRODUCTION RÖHM GMBH (DE) 2025-09-18 US disclosed
US-20250277067-A1 POLY(METH)ACRYLAT IMPACT MODIFIER WITH IMPROVED OPTICAL PROPERTIES AND METHOD FOR ITS PRODUCTION RÖHM GMBH (DE) 2025-09-04 US disclosed
EP-0307775-A2 Water dispersible, modified polyurethane thickener with improved high shear viscosity in aqueous systems RHEOX INTERNATIONAL, INC. (US) 1989-03-22 EP disclosed
US-4701434-A Promoted nickel and/or cobalt catalyst, its use, and process performed in its presesnce BEROL KEMI AB (SE) 1987-10-20 US disclosed
EP-0090748-B1 STABILIZATION PROCESS FOR POLYVINYL CHLORIDE POLYMERS, STABILIZING COMPOSITIONS FOR CARRYING OUT THE PROCESS AND POLYMERS SO STABILIZED RHONE-POULENC CHIMIE (FR) 1986-11-05 EP disclosed
EP-0146508-A2 Promoted nickel and/or cobalt catalyst, its use and process performed in its presence BEROL NOBEL AB (SE) 1985-06-26 EP disclosed
US-4250343-A DEHYDRATION OF THE ALKANEDIOL USING NEUTRAL SODIUM, LITHIUM, BARIUM, OR STRONTIUM PYROPHOSPHATE AS CATALYST CHEMISCHE WERKE HULS AKTIENGESELLSCHAFT (DE) 1981-02-10 US disclosed
US-3993605-A SURFACTANT OF VICINAL ALKANEDIOL ESTERS CHEMISCHE WERKE HULS AKTIENGESELLSCHAFT 1976-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028440-A1 Curable Composition for Producing Transparent Orthodontic Attachments SMCHD1, SMC2, SMC1A LMNA 1007/4885GPR84 3412/4885SPHK1 4200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.